Miguel Mendes
Research Subjects
Miguel Mendes has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Hélder Dores
Department of Cardiology, Hospital da Luz Lisboa, Luz Saúde, 1600-209 Lisbon, Portugal
1 shared publication - José Pedro Neves
Serviço de Cirurgia Cardiotorácica, Hospital de Santa Cruz - Centro Hospitalar de Lisboa Ocidental, Rua Professor Reynaldo dos Santos, 2795-523 Carnaxide, Portugal
1 shared publication - João Abecasis
Cardiology Department, Hospital de Santa Cruz, Unidade Local de Saúde de Lisboa Ocidental , Av. Prof. Dr. Reinaldo dos Santos, Carnaxide, Lisbon 2790-134
1 shared publication - Regina Ribeiras
Department of Cardiology, Hospital Santa Cruz, Unidade Local de Saúde Lisboa Ocidental, 2790-134 Carnaxide, Portugal
1 shared publication
Latest Publications
- Open Access
- 1 January 2014
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 33 (1) , 65-66
Comentário a «Tendências da mortalidade por doença coronária padronizada pela idade na União Europeia ao longo de três décadas: 1980-2009»
- 1 January 2014
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 33 (1) , 65-66
Open AccessComentário a «Tendências da mortalidade por doença coronária padronizada pela idade na União Europeia ao longo de três décadas: 1980-2009»
- Open Access
- 23 February 2012
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 10 (1) , 7
Uncommon acquired Gerbodedefect following extensive bicuspid aortic valve endocarditis
Gerbode defect is a rare type of left ventricle to right atrium shunt. It is usually congenital in origin, but acquired cases are also described, mainly following infective endocarditis, valve replacement, trauma or acute myocardial infarction. We report a case of a 50-year-old man who suffered an extensive and complex infective endocarditis involving a bicuspid aortic valve, the mitral-aortic intervalvular fibrosa and the anterior leaflet of the mitral valve. After dual valve replacement and annular reconstruction, a shunt between the left ventricle and the right atrium - Gerbode defect, and a severe leak of the mitral prosthesis were detected. Reintervention was performed with successful shunt closure with an autologous pericardial patch and paravalvular leak correction. No major complications occurred denying the immediate post-surgery period and the follow-up at the first year was uneventful.
- 23 February 2012
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 10 (1) , 7
Open AccessUncommon acquired Gerbodedefect following extensive bicuspid aortic valve endocarditis
Gerbode defect is a rare type of left ventricle to right atrium shunt. It is usually congenital in origin, but acquired cases are also described, mainly following infective endocarditis, valve replacement, trauma or acute myocardial infarction. We report a case of a 50-year-old man who suffered an extensive and complex infective endocarditis involving a bicuspid aortic valve, the mitral-aortic intervalvular fibrosa and the anterior leaflet of the mitral valve. After dual valve replacement and annular reconstruction, a shunt between the left ventricle and the right atrium - Gerbode defect, and a severe leak of the mitral prosthesis were detected. Reintervention was performed with successful shunt closure with an autologous pericardial patch and paravalvular leak correction. No major complications occurred denying the immediate post-surgery period and the follow-up at the first year was uneventful.
- 1 January 2011
- Published by Radcliffe Medical Media Ltd in European Cardiology Review
- Vol. 7 (1)
The Role of Cardiac Rehabilitation in Achieving Optimal Treatment
The clinical practice of European cardiologists is directed by the European Society of Cardiology’s guidelines for several clinical entities, in which ‘optimal medical treatment’ (a specific drug regime and lifestyle measures) for each syndrome is defined. The described pharmacotherapy is composed of several drugs, since the clinical research behind the recommendations is conducted using an ‘on top of’ strategy. For example, an asymptomatic patient after an acute coronary syndrome with normal ventricular function and without residual ischaemia has an indication to take at least four types of tablets per day, which is difficult to understand and to follow long term. The cost of the drugs is sometimes beyond the patient’s means, which also contributes to lower compliance. A clinician’s practice is usually very busy, which means it is almost impossible to perform patient education and promote adherence to drug therapy and lifestyle changes. Cardiac rehabilitation, as proved by the Global Secondary Prevention Strategies to Limit Event Recurrence after Myocardial Infarction (GOSPEL) study, may be considered the best available secondary prevention programme, as it educates patients and promotes adherence to the optimal medical treatment to a greater degree than usual care.
- 1 January 2011
- Published by Radcliffe Medical Media Ltd in European Cardiology Review
- Vol. 7 (1)
The Role of Cardiac Rehabilitation in Achieving Optimal Treatment
The clinical practice of European cardiologists is directed by the European Society of Cardiology’s guidelines for several clinical entities, in which ‘optimal medical treatment’ (a specific drug regime and lifestyle measures) for each syndrome is defined. The described pharmacotherapy is composed of several drugs, since the clinical research behind the recommendations is conducted using an ‘on top of’ strategy. For example, an asymptomatic patient after an acute coronary syndrome with normal ventricular function and without residual ischaemia has an indication to take at least four types of tablets per day, which is difficult to understand and to follow long term. The cost of the drugs is sometimes beyond the patient’s means, which also contributes to lower compliance. A clinician’s practice is usually very busy, which means it is almost impossible to perform patient education and promote adherence to drug therapy and lifestyle changes. Cardiac rehabilitation, as proved by the Global Secondary Prevention Strategies to Limit Event Recurrence after Myocardial Infarction (GOSPEL) study, may be considered the best available secondary prevention programme, as it educates patients and promotes adherence to the optimal medical treatment to a greater degree than usual care.
- 1 October 2010
- Published by Springer Nature
- p. 3-29
General Principles of Exercise Testing in Cardiac Rehabilitation
- 1 October 2010
- Published by Springer Nature
- p. 3-29
General Principles of Exercise Testing in Cardiac Rehabilitation